Cargando…
From transcriptional regulation to drugging the cancer epigenome
Jay Bradner discusses the opportunities and challenges for the study and therapeutic targeting of the cancer epigenome, as well as innovative approaches to drug discovery.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295578/ https://www.ncbi.nlm.nih.gov/pubmed/25593599 http://dx.doi.org/10.1186/s13073-014-0123-1 |
| Sumario: | Jay Bradner discusses the opportunities and challenges for the study and therapeutic targeting of the cancer epigenome, as well as innovative approaches to drug discovery. |
|---|